This is biology’s century. Amazing new medicines, technologies, and sources of data appear seemingly every day. Never before has the future of health and medicine been so promising. With this promise comes new hurdles and exciting challenges.
Join us at biotech’s event horizon to discuss how to unlock the full promise of this new era for patients.
President of Product Development and Chief Medical Officer, Verily
Nobel Laureate, Co-inventor of CRISPR Technology; President, Innovative Genomics Institute
Chief Executive Officer, Verily
Founder, Khosla Ventures
Co-Founder and Co-Executive Director, Initiative for Medicines, Access & Knowledge (I-MAK); 2022 MacArthur Fellow
Co-Founder and Managing Director, ARCH Venture Partners
Chairman of the Board of Directors and Chief Executive Officer, Gilead Sciences
Co-Founder of the Emily Whitehead Foundation
General Partner, Andreessen Horowitz
Sponsor Speaker
Executive Vice President, Global Research, and Chief Scientific Officer, Vertex Pharmaceuticals
Patient & Patient Advocate, writer of Daily Trojan’s “Chronically Catherine”
Professor, Wake Forest School of Medicine, and Co-director, Weight Management Center, Atrium Health Wake Forest Baptist
Professor of Epidemiology and Nutrition, Harvard T.H. Chan School of Public Health
Chief Medical Officer, DELFI Diagnostics
Chief Operating Officer, IDEA Pharma
Sponsor Speaker
Vice President, Oncology, Therapeutic Area Head, Amgen
Editor in Chief, JAMA; Professor of Epidemiology and Biostatistics, UCSF
Sponsor Speaker
SVP, Head of Research, Vertex Pharmaceuticals
Associate Dean and Professor, UCSF School of Medicine
VP, Epidemiology and Distinguished Scientist, GRAIL LLC
Partner, Innovation Endeavors
Co-founder, Every Cure; Director, CSTL, at the University of Pennsylvania
Roy A. Roberts & Regents Distinguished Professor of Economics, Director, Institute for Policy & Social Research, University of Kansas
Ph.D. Student, Bioengineering at UC San Diego
Chief Executive Officer and President, Nkarta
Executive Chair and Co-Founder, Vanna Health
Virtual Speaker
Visiting Professorial Fellow, University of Oxford; Professorial Fellow Emerita, University of Manchester
Professor, University of Pennsylvania
Sponsor Speaker
Chief Executive Officer, ZS
Professor of Neurosurgery, MD Anderson Cancer Center
CEO, D2G Oncology
Associate Vice Provost & Associate Dean for Postdoctoral Affairs, Stanford University
Co-founder & CEO, Eko Health
Sponsor Speaker
Co-founder & CEO, PicnicHealth
Professor, Department of Molecular Pathobiology, New York University
Emeritus Professor of Pediatrics, UCSF
Sponsor Speaker
Chief Development Officer and Executive Vice President, Pfizer
Sponsor Speaker
Medical Director and SVP of Strategy, Doximity
Sponsor Speaker
Chief Medical Officer, Teladoc Health
Cardiologist and Professor of Medicine at the University of California, San Francisco
Sponsor Speaker
Vice President and Chief Medical Partner, Neurology, Genentech
Partner, Venrock
CEO & Founder Bayesian Health, Inc. / Endowed Chair & AI Prof at Johns Hopkins
Group Partner, Y Combinator
Director, Center for Cellular Engineering, Memorial Sloan Kettering Cancer Center
Chief Data Scientist, Stanford Healthcare
Life Science Leader, Patient Advocate and Co-Founder of the More Moments More Memories Foundation
Sponsor Speaker
Executive Vice President, Research and Development, Horizon Therapeutics
Sponsor Speaker
Senior Vice President and General Manager of U.S. Business Operations, Amgen
President & Co-founder, Emily Whitehead Foundation
Distinguished Professor of Engineering, Boston University
Moderator
Co-founder & Executive Editor, STAT
Moderator
Cardiovascular Disease Reporter, STAT
Moderator
Chronic Disease Reporter, STAT
Moderator
Biotech Startups and Venture Capital Reporter, STAT
Moderator
Senior Writer, Biotech, STAT
Moderator
Special Projects Editor, STAT
Moderator
Senior Writer, Medicine; Editorial Director of Events, STAT
Moderator
Medical Devices Reporter, STAT
Moderator
National Science Correspondent, STAT
Moderator
Branded Content Editor, STAT
Moderator
Science Writer, STAT
Moderator
Health Tech Correspondent, STAT
Moderator
Pharmalot Columnist, Senior Writer, STAT
Moderator
General Assignment Reporter; Associate Editorial Director of Events, STAT
Moderator
National Technology Correspondent, STAT
Moderator
Senior News Editor, STAT
Moderator
West Coast Biotech & Life Sciences Reporter, STAT
Registering for a group? Save 20% on each ticket when you buy 5 or more. When purchasing your ticket, add additional attendees and the discount will apply to your cart.
STAT is committed to making this summit accessible. If our tickets are out of your price range, please feel free to email us at [email protected] to inquire about academic, nonprofit, government, and patient discounts.
You can participate in the virtual programming from the comfort of your own computer or be a part of the program at the Commonwealth Club in San Francisco.
© Mapbox © OpenStreetMap
Agenda sessions, speakers, and timing are subject to change. Additional sessions will be announced in the coming weeks
A decade ago, Emily Whitehead was the world’s first pediatric CART-T patient. Now, she is a healthy teenager, living cancer-free with doctors claiming she is effectively cured of the disease. Hear her story.
A decade ago, cell therapy seemed like the future of cancer therapy. Is that hope intact?
Taking learnings from the company’s Covid-19 vaccine and treatment development programs, Pfizer is now applying the same urgency and ambition to other critical therapies and vaccines. Hear how the company plans to accelerate timelines to bring more breakthroughs to more patients faster.
One of the biggest scientific advances of 2022 was the realization that multiple sclerosis may be caused by a common viral infection. What other diseases might actually be caused by viral infection? Two candidates: Alzheimer’s and ALS.
Priti Krishtel has become one of the most visible critics of the patent system and the pharmaceutical industry’s use of it. Hear how she believes changes to it could improve health equity and global health.
From alleviating physician burnout to detecting disease while it’s still treatable, the technology already exists to fix most of today’s health care ills — but only when paired with a human touch. AI adoption depends on trust — not trust in the algorithms but trust in the processes and policies that have validated them and in the health care provider they believe is invested in their health.
Vinod Khosla, the co-founder of Sun Microsystems, is one of the biggest names in the history of venture capital. He wrote the first checks for OpenAI and Impossible. Now he believes that artificial intelligence is poised to change health care. Hear him describe his vision.
STAT’s annual tournament for scientific innovation takes the stage! Three finalists in this year’s competition will present their discoveries to our panel of expert judges, and one will be selected as our “STAT Madness All-Star” by event attendees.
The pandemic showed telehealth’s promise. Now patients and providers are bracing for a new regulatory landscape—and sought-after weight-loss drugs are fueling a fresh wave of scrutiny for virtual prescribing. Where do we go from here?
Researchers are finding ways to detect cancer early with a simple blood test using DNA sequencing. But how do we know when these tests are ready for wide use? Hear from experts on the balance between early detection and overtreatment.
With early-career life scientists leaving the ivory tower at historic rates, the future of academic research is at stake. Does this system need to be tweaked or radically transformed?
The pandemic showed that mobile medicine can be harnessed to drive a paradigm shift in health care delivery and improve patient access to care. Hear how a time of crisis and uncertainty can provide a foundation for innovation and efficiency.
The collapse of SVB and a sluggish IPO market spell uncertainty for biotech companies. Hear from a group of leading investors and startup founders about the state of the industry.
Brought to you by 2023 STAT Madness sponsor, Vertex
STAT is throwing a Mad party. Come network with STAT reporters and other brilliant Madness minds (or perhaps your toughest Madness rivals!) at the best tiki bar in San Francisco! This after party will take place offsite at Pagan Idol, located at: 375 Bush St, San Francisco, CA 94104. Open to all summit attendees. Brought to you by 2023 STAT Madness sponsor, Vertex.
In 2014, David Fajgenbaum took a 25-year-old drug and sent the rare disease that was killing him into remission. Now he’s using artificial intelligence to do the same for other rare diseases. Hear about the progress his team is making.
Verily has long been known for its big ambitions to transform health care. Under a new leader, it is now channeling its investments into an effort to transform clinical trials for the 21st century. Hear what’s next.
The pace of innovations quickens daily. How should companies collaborate with patients and doctors to ensure the latest scientific knowledge about how to treat and prevent disease gets to the people who need it?
For perhaps the first time ever new medicines are having a substantial impact on obesity. They promise to improve and maybe even save people’s lives. But do they also pose risks? How do we get the most out of these drugs?
IDEA Pharma unveils the 12th annual edition of its ranking of the companies that do the best jobs creating medicines and bringing them to market.
After several years of stumbles, the leader in HIV treatment has finally begun to establish a presence in cancer. Hear what’s next, about the company’s plan to deliver 10 transformative medicines by 2030, and about the state of biotech writ large.
Considerable progress has been made in understanding brain health, but much remains to be done. Hear how collaborations in personalized health care and emerging health technology are helping to push the boundaries of scientific understanding.
Bob Nelsen has had a sometimes prophetic, always audacious view fo the future of biotechnology for decades. His latest bets have involved massive raises of capital and potentially crazy ideas about cell therapy, bodily regeneration, and manufacturing. Hear why he thinks his go-big-or-go-home model will continue to deliver.
As the gene editing technology hits the mainstream, CRISPR co-inventor Jennifer Doudna shares her predictions for what’s next and what still needs to be done to make this potentially life-changing technology more accessible. Are our predictions — good or bad — founded in reality?
The ability of AI models to answer medical questions and quickly summarize information has awakened the world to their potential. But they also commit grievous errors and make things up. So how can health care organizations reap the benefits while minimizing the risks? Let’s put aside the hype.
Understanding the patient experience can transform how a drug is developed. In Sjögrens disease, which causes dryness, this led Horizon scientists to pay attention to sexual health. In lupus, it meant recruiting patients with a diverse array of skin tones. Learn how listening to patients can mean better science.
We may be done with Covid-19, but the virus isn’t yet done with us. Our experts have been go-to sources for trusted information throughout the pandemic. They’ll discuss what surprised them most about this massive public health crisis, how to navigate continuing uncertainty, and what they think lies ahead as the virus continues to surprise us.
As director of the National Institute of Mental Health, Thomas Insel articulated a bold vision: that understanding of psychiatric illness could be reduced to biology, not just an often qualitative examination of mental state. But he also had a front-row seat to the difficulty of using health tech to care for people with mental health disorders. Learn from his vision – and his experience.
Open to all summit attendees! Sponsored by Real Chemistry.
Sign up today for summit news and updates
Email us any questions or concerns
